2
Red · act now
3
Amber · monitor
2
Green · opportunity
Red alerts: act now
Red Recall · November 2026
Moringa leaf powder Salmonella outbreak: 119 illnesses in 36 states, at least four brands implicated

FDA's outbreak investigation traces the illnesses to contaminated moringa leaf powder used across at least four supplement brands: Live it Up Super Greens powders and stick packs, Tnvitamins/Doctor's Pride moringa capsules, and Why Not Natural moringa capsules. FDA closed the investigation on March 17, 2026, then reopened it on May 27, 2026. As of that update the status is ongoing: 119 illnesses across 36 states, 32 hospitalizations, no deaths. No FDA update has been found since. Clients sourcing moringa should confirm their supplier is not one of those implicated.

Red Claim enforcement · November 2026
FTC seeks a contempt order against Amare Global over repeat health claims

In June 2026 the FTC filed a motion seeking a contempt order against Amare Global and three individuals, alleging continued unsubstantiated depression, anxiety, and ADHD claims after an earlier settlement agreement. Escalation from standard enforcement to contempt shows the FTC treating repeat violations of existing orders as a priority. Any client operating under a consent order should treat compliance as a live obligation.

Consumer search and social signals also inform velocity rating.

Amber alerts: monitor
Amber Regulatory · November 2026
NMN reinstated as lawful but still requires NDI notification

FDA reinstated NMN as a legal dietary ingredient in 2025. Companies without a filed New Dietary Ingredient Notification remain exposed unless sourcing from a supplier that already filed one. A full year on, no new litigation, enforcement, or NDIN filing has surfaced.

Consumer search and social signals also inform velocity rating.

Confirm NDIN coverage
Amber Safety risk · November 2026
Methylene blue biohacker use is growing with no human safety data behind cognitive claims

Social-driven demand for methylene blue as a nootropic is outrunning safety data. Syndicated public radio coverage has now set out the serotonin-toxicity and G6PD-deficiency risks, widening mainstream awareness. No new safety or regulatory data accompanies the added visibility. Treat this as a liability watch item, not a formulation opportunity.

Consumer search and social signals also inform velocity rating.

Monitor social trend
Amber Quality alert · November 2026
Kids magnesium gummies withdrawn for undeclared melatonin

The UK MHRA advised parents and caregivers to stop using Nutrition Ignition Kids Magnesium Glycinate Gummies, sold online as a food supplement, after it found undeclared melatonin, a prescription-only medicine in the UK. The advisory does not confirm whether US sale occurred. Because the product was sold online, confirm distribution scope before treating this as UK-only. Brands using shared gummy lines should confirm cross-contamination controls.

Consumer search and social signals also inform velocity rating.

Audit co-manufacturer controls
Green signals: opportunities
Opportunity Regulatory · November 2026
FDA enforcement discretion on DSHEA disclaimer placement reduces label compliance burden

FDA's December 2025 letter said it would not enforce the per-panel disclaimer requirement while rulemaking proceeds. No further action has followed. Clients redesigning labels this cycle can consolidate disclaimer placement now, cutting packaging costs without waiting for the final rule.

Opportunity Formulation · November 2026
Postbiotics gain shelf-stable formulation flexibility, and human trials are now enrolling

Postbiotics are gaining formulation flexibility into shelf-stable formats, opening categories such as bars and beverages that live probiotics could never enter. New ClinicalTrials.gov listings show active human enrollment across gut-health, inflammation, and immune endpoints.

Consumer search and social signals also inform velocity rating.

"The regulatory and claim environment in dietary supplements has never been more consequential. Getting the evidence framing right is as important as the formulation itself."

Schedule a consultation →